Article
Global screening and genetic engineering of Tistrella enable sustainable production of didemnin drugs
2023-05-04
Abstract excerpt
<title>Abstract</title> <p>The <italic>Tistrella</italic> genus can produce the cyclic depsipeptide didemnin B, but the biosynthetic origin of its analogue, plitidepsin, remains unknown. Plitidepsin is an approved anticancer drug and an anti-COVID-19 agent in phase III clinical trials. Here, we employed a novel approach that combined microbial and chemical synthesis to produce plitidepsin. We first investigated t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8f3b931c-9867-5792-817e-9d77b086f19e
- DOI
- 10.21203/rs.3.rs-2879035/v1
